PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy

Month: November 2020

PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy

Roden — November 20, 2020 — PureIMS, a clinical stage pharmaceutical and medication systems company focused on developing and commercializing innovative inhaled therapies for systemic and respiratory diseases has appointed Bram van Dijck to the role of Chief Executive Officer (CEO) with immediate effect. Mr. van Dijck joins PureIMS from the Grünenthal Group where he […]